If we can figure out who should get Avastin, when and for how long, we may find it has a place in breast cancer. But until we answer those questions, we should not be giving it to everybody because we hope it will help someone.
Read Whole Story
A Food and Drug Administration panel voted today to revoke Avastin's approval for treatment of breast cancer.
The panel voted 6-0 to r...
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.